XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Common Stock
6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Common Stock Common Stock        
As of June 30, 2022 and December 31, 2021, there were 49,364,981 and 53,299,738 shares of our common stock outstanding, respectively.
During the three months ended June 30, 2022 and 2021, we issued 76,426 and 36,044 shares of common stock, respectively. During the six months ended June 30, 2022 and 2021, we issued 171,757 and 127,287 shares of common stock, respectively. These shares were issued upon either the satisfaction of required conditions under our share-based compensation plans or the purchase of common stock pursuant to our employee stock purchase plan.
We have paid quarterly dividends since October 25, 2011. We currently pay a regular quarterly dividend of $0.13 per share. Subsequent to June 30, 2022, our Board of Directors (the “Board”) announced its intention to increase the regular quarterly divided to $0.15 per share commencing with the dividend to be paid in October 2022.
In September 2011, the Board authorized a share repurchase program allowing us to begin repurchasing shares of our outstanding common stock. Subsequently, the Board has from time to time increased the amount authorized for repurchases under such program. Since the inception of the repurchase program, the Board has authorized us to repurchase up to $1.65 billion of our outstanding common stock. During the six months ended June 30, 2022, we repurchased approximately 4.1 million shares of our common stock for approximately $454.3 million. Since the inception of the repurchase program through June 30, 2022, we have repurchased approximately 23.3 million shares of our common stock for approximately $1.55 billion. As of June 30, 2022, there remained authorization for us to repurchase approximately $96.1 million of our shares. Subsequent to June 30, 2022, the Board authorized us to repurchase up to an additional $500.0 million of our outstanding common stock. The repurchase program has no expiration date, does not obligate the Company to acquire any particular amount of common stock, and may be suspended, recommenced, or discontinued at any time or from time to time without prior notice. We may repurchase our shares from time to time to the extent permitted by securities laws and other legal requirements, including provisions in our 2020 Credit Agreement placing limitations on such repurchases.